Sign In

Sign In Register for Free

Join our 300,000+ users: Register for FREE

Sign In

Sign In Get Live Data

Less Ads, More Data, More Tools Register for FREE

REMOVE ADS

Latest Share Chat

REMOVE ADS

Basilea Pharma Company Research (0QNA)

Basilea Pharma Information

Share Price Information for Basilea Pharma (0QNA)

Share Price is delayed by 15 minutes

Get Live Data

49.85 0.00 (0.00%)

Bid:

0.00

Ask:

0.00

Spread: 0.00 (0.00%)

Market Cap:

0QNA Live Price

Last checked at -

London Stock Exchange

Intraday Basilea Pharma Share Chart

This share is an international stock.

REMOVE ADS

Date	Research	Company
27-Mar-26	BAL2420 clinical entry expands antibiotic pipeline	Edison
02-Feb-26	An emphatic start to 2026	Edison
29-Sep-25	BARDA backs latest antibacterial programme	Edison
01-Sep-25	Gearing up for the next growth phase	Edison
15-Aug-25	New acquisition bolsters antibacterial franchise	Edison
31-Jul-25	Advancing into Phase III in mould Infections	Edison
25-Jul-25	Innovation meets execution in anti-infectives	Edison
21-May-25	Zevtera hits the shelves in the US	Edison
19-Feb-25	Another year, another market beat	Edison
06-Feb-25	Encouraging start to the year for Cresemba	Edison
17-Dec-24	Basilea Pharmaceutica - Partner in place for US commercialisation o...	Edison
11-Oct-24	Basilea Pharmaceutica - Milestone march continues for Cresemba	Edison
24-Sep-24	Basilea Pharmaceutica - BARDA backs Basilea’s anti-infectives progr...	Edison
09-Sep-24	Basilea Pharmaceutica - H2 rewards continue: US$25m Cresemba milestone	Edison
28-Aug-24	Basilea Pharmaceutica - EU paediatric approval triggers CHF10m mile...	Edison